BIOMAT Database Logo BIOMAT Database Logo

Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations. 1997

J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Department of Nephrology, Hospital Ntra. Sra. de Candelaria, S/C de Tenerife, Canary Islands, Spain.

To date, the magnitude, causes, and factors that govern urea rebound are not clearly defined. This study was undertaken to determine the possible influence of the biocompatibility of dialyzer membrane on urea rebound and to assess the participation of rebound in the calculation of Kt/V-urea by different methods. Blood urea samples were obtained before, and at 2, 30, and 60 min posthemodialysis in 8 patients undergoing dialysis with 2 different membranes, Cuprophan and polyacrylonitrile (24 sessions with each membrane). Urea rebound was documented in all patients. The degree of rebound was large, 20%, and it was achieved within 30 min after the end of dialysis. Urea rebound was observed with both Cuprophan and polyacrylonitrile membranes, without significant differences. Kt/V-urea significantly decreased (p < 0.001) by all methods when urea rebound was incorporated. We conclude that urea rebound is clinically very important and is not influenced by the biocompatibility of the dialyzer membrane. This phenomenon must be taken into account in the calculation of Kt/V; otherwise, it might be overestimated.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000180 Acrylic Resins Polymers of high molecular weight which are derived from acrylic acid, methacrylic acid or other related compounds and are capable of being molded and then hardened to form useful components. Acrylic Resin,Resin, Acrylic,Resins, Acrylic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Accuracy of Kt/V estimations in high-flux haemodiafiltration using per cent reduction of urea: incorporation of urea rebound.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Evaluation and prediction of urea rebound and equilibrated Kt/V in the pediatric hemodialysis population.
July 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Urea rebound and delivered Kt/V determination with a continuous urea sensor.
March 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Quest for postdialysis urea rebound-equilibrated Kt/V with only intradialytic urea samples.
September 1999, Kidney international,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Evaluation of hemodialysis adequacy using online Kt/V and single-pool variable-volume urea Kt/V.
January 2008, International urology and nephrology,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V.
December 1996, Kidney international,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Whole body Kt/V from dialysate urea measurements during hemodialysis.
November 1998, Journal of the American Society of Nephrology : JASN,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Kt/V in CAPD by different estimations of V.
August 1995, Kidney international,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Calculating Standard Kt/V during Hemodialysis Based on Urea Mass Removed.
January 2019, Blood purification,
J F Navarro, and N del Castillo, and J L Fernández, and M L Macía, and M L Méndez, and J Chahin, and V García-Nieto, and E Gallego, and C Mora-Fernández, and J García
Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate.
June 1993, Kidney international. Supplement,
Copied contents to your clipboard!